Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
12.64
-0.06 (-0.47%)
At close: Jun 12, 2026, 4:00 PM EDT
12.71
+0.07 (0.55%)
After-hours: Jun 12, 2026, 7:21 PM EDT
Q32 Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 50.75 | 48.3 | 77.97 | 25.62 | 33.99 | 108.38 |
Short-Term Investments | - | - | - | - | 141.04 | 47.49 |
Cash & Short-Term Investments | 50.75 | 48.3 | 77.97 | 25.62 | 175.03 | 155.87 |
Cash Growth | -22.50% | -38.05% | 204.35% | -85.36% | 12.29% | -28.31% |
Other Current Assets | 6.45 | 6.75 | 3.91 | 3.1 | 5.99 | 36.04 |
Total Current Assets | 57.2 | 55.05 | 81.88 | 28.72 | 181.02 | 191.91 |
Net Property, Plant & Equipment | 5.83 | 6.08 | 7.09 | 8.08 | 21.64 | 17.86 |
Long-Term Investments | - | - | 2.6 | - | 25.81 | - |
Other Long-Term Assets | 0.65 | 0.65 | 0.76 | 10.26 | - | 1.95 |
Total Assets | 63.68 | 61.78 | 92.33 | 47.06 | 228.47 | 211.72 |
Accounts Payable | 0.65 | 0.88 | 2.99 | 3.47 | 1.14 | 2.37 |
Accrued Expenses | 3.78 | 4.23 | 7.48 | 9.76 | 18.72 | 11.41 |
Current Portion of Long-Term Debt | 6.24 | 6.24 | 3.1 | 0.88 | - | - |
Current Portion of Leases | - | - | - | - | 1.56 | 0.25 |
Unearned Revenue | - | - | - | - | 1.16 | 3.21 |
Other Current Liabilities | - | - | 2.9 | - | - | - |
Total Current Liabilities | 10.67 | 11.35 | 16.47 | 14.11 | 22.58 | 17.23 |
Long-Term Debt | 1.94 | 3.47 | 9.56 | 43.18 | - | - |
Long-Term Leases | 4.75 | 4.94 | 5.64 | 6.25 | 27.92 | 23.69 |
Other Long-Term Liabilities | - | - | 55 | 55 | - | 1.16 |
Total Long-Term Liabilities | 6.69 | 8.42 | 70.19 | 104.42 | 27.92 | 24.84 |
Total Liabilities | 17.36 | 19.76 | 86.66 | 118.53 | 50.49 | 42.07 |
Common Stock | 0 | 0 | 0 | 0 | 0.01 | 0.01 |
Additional Paid-in Capital | 258.91 | 247.01 | 240.49 | 4.16 | 607.51 | 593.78 |
Accumulated Other Comprehensive Income | - | - | - | -187.08 | -0.4 | -0.01 |
Retained Earnings | -212.6 | -204.99 | -234.81 | - | -429.14 | -424.13 |
Total Common Shareholders' Equity | 46.31 | 42.01 | 5.68 | -182.92 | 177.98 | 169.65 |
Minority Interest | - | - | - | 111.45 | - | - |
Shareholders' Equity | 46.31 | 42.01 | 5.68 | -71.48 | 177.98 | 169.65 |
Total Liabilities & Equity | 63.68 | 61.78 | 92.33 | 47.06 | 228.47 | 211.72 |
Total Debt | 12.93 | 14.65 | 18.29 | 50.3 | 29.48 | 23.93 |
Net Cash (Debt) | 37.82 | 33.65 | 59.68 | -24.69 | 145.55 | 131.94 |
Net Cash Growth | 12.40% | -43.62% | - | - | 10.32% | -34.68% |
Net Cash Per Share | 2.96 | 2.73 | 6.18 | -8.04 | 47.39 | 42.96 |
Book Value | 46.31 | 42.01 | 5.68 | -182.92 | 177.98 | 169.65 |
Book Value Per Share | 3.62 | 3.41 | 0.59 | -59.56 | 57.95 | 55.24 |
Tangible Book Value | 46.31 | 42.01 | 5.68 | -182.92 | 177.98 | 169.65 |
Tangible Book Value Per Share | 3.62 | 3.41 | 0.59 | -59.56 | 57.95 | 55.24 |